Discontinued — last reported Q4 '25
Eli Lilly Total Assets decreased by 2.1% to $112.48B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 42.9%, from $78.71B to $112.48B. Over 5 years (FY 2020 to FY 2025), Total Assets shows an upward trend with a 19.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Growth indicates business expansion and capital investment, while a decline might suggest asset divestitures or significant depreciation.
The sum of all resources owned or controlled by the company, including both current items like cash and non-current item...
Used to calculate Return on Assets (ROA); tech giants typically have massive asset bases driven by cash reserves and infrastructure.
total_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $47.81B | $48.19B | $48.81B | $46.92B | $47.06B | $47.46B | $49.49B | $53.16B | $54.81B | $57.92B | $64.01B | $63.94B | $71.87B | $75.61B | $78.71B | $89.39B | $100.92B | $114.94B | $112.48B |
| QoQ Change | — | +0.8% | +1.3% | -3.9% | +0.3% | +0.8% | +4.3% | +7.4% | +3.1% | +5.7% | +10.5% | -0.1% | +12.4% | +5.2% | +4.1% | +13.6% | +12.9% | +13.9% | -2.1% |
| YoY Change | — | — | — | — | -1.6% | -1.5% | +1.4% | +13.3% | +16.5% | +22.0% | +29.3% | +20.3% | +31.1% | +30.5% | +23.0% | +39.8% | +40.4% | +52.0% | +42.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.